TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Evomed AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
186
|
179
|
196 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
10
|
12
|
-6 |
| EBITDA |
12
|
15
|
-3 |
| Total assets |
44
|
48
|
42 |
| Current assets |
40
|
41
|
33 |
| Current liabilities |
13
|
10
|
14 |
| Equity capital |
31
|
38
|
28 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
70.5%
|
79.2%
|
66.7% |
| Turnover per employee |
186
|
179
|
65 |
| Profit as a percentage of turnover |
5.4%
|
6.7%
|
-3.1% |
| Return on assets (ROA) |
22.7%
|
25.0%
|
-11.9% |
| Current ratio |
307.7%
|
410.0%
|
235.7% |
| Return on equity (ROE) |
32.3%
|
31.6%
|
-21.4% |
| Change turnover |
13
|
-18
|
-42 |
| Change turnover % |
8%
|
-9%
|
-18% |
| Chg. No. of employees |
0
|
-2
|
0 |
| Chg. No. of employees % |
0%
|
-67%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.